Secretory leukocyte peptidase inhibitor and lung cancer.
about
Mechanisms of granulin deficiency: lessons from cellular and animal modelsSignaling from the secretory granule to the nucleus: Uhmk1 and PAMSecretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cellsTLR ligands, but not modulators of histone modifiers, can induce the complex immune response pattern of endotoxin tolerance in mammary epithelial cells.WAP four-disulfide core domain protein 2 promotes metastasis of human ovarian cancer by regulation of metastasis-associated genesOral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumAntitumor Efficacy of SLPI Promoter-Controlled Expression of Artificial microRNA Targeting EGFR in a Squamous Cell Carcinoma Cell Line.Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion.Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer.Effect of Pingchuan Guben decoction on patients with chronic obstructive pulmonary disease: Results from a randomized comparative effectiveness research trialIdentification and characterization of Wfdc gene expression in the male reproductive tract of the rat.The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
P2860
Q26824221-9B7ACCDA-C223-4CA1-B6E0-82D8A40B31D5Q28568254-7FC81C3A-D7A7-4518-BB08-38DED12E779EQ33596742-126FE42B-72EF-4943-A074-A61BDBB780E2Q33620264-E6EB4856-808E-4CCE-9588-68245FB73F65Q33876850-51FD4568-B7A2-4732-BB0B-E27FE6D5261EQ34050632-2D9D715F-247F-4C27-A827-7B2ABED554FEQ35957217-FE316978-D9AE-4F75-BCC7-4122AA2B493CQ38720608-3FF7B1F7-92EE-4CE0-BED2-D11152ECE3F8Q38794223-7660CCC7-1854-49DC-9C11-B4FDD77928C2Q39655858-F08F321D-27A2-4E83-9755-6DFE5E372178Q40385469-3871B290-4D29-462E-9B62-F226FFAE9940Q42205221-DFAC1785-6B2C-4BDB-92AF-0AADFD18B4AFQ42321812-CD7E31B6-5928-40ED-8677-5EEF77A1EE6CQ42376323-C866D216-E2E9-4D35-A169-2CE6C7B7D7E1Q46217516-88CB4B1C-2A3E-486C-A835-D4C29DA0A2B6Q52642415-804E9918-2A04-45BE-968A-C7D3256BC8F2
P2860
Secretory leukocyte peptidase inhibitor and lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Secretory leukocyte peptidase inhibitor and lung cancer.
@en
Secretory leukocyte peptidase inhibitor and lung cancer.
@nl
type
label
Secretory leukocyte peptidase inhibitor and lung cancer.
@en
Secretory leukocyte peptidase inhibitor and lung cancer.
@nl
prefLabel
Secretory leukocyte peptidase inhibitor and lung cancer.
@en
Secretory leukocyte peptidase inhibitor and lung cancer.
@nl
P2093
P2860
P1433
P1476
Secretory leukocyte peptidase inhibitor and lung cancer.
@en
P2093
Takuji Suzuki
Tatsuro Fukuhara
Toshiaki Kikuchi
Toshihiro Nukiwa
P2860
P304
P356
10.1111/J.1349-7006.2008.00772.X
P577
2008-05-01T00:00:00Z